Umbelliferone β-D-galactopyranoside from Aegle marmelos (L.) corr. an ethnomedicinal plant with antidiabetic, antihyperlipidemic and antioxidative activity

Table 2 Effect of umbelliferone β-D-galactopyranoside on blood glucose levels in oral glucose tolerance test in normoglycemic rats

S. No.	Treatment	Dose	Mean blood glucose concentration ± SEM (mg/dl)
			Time 0 min	Time 30 min	Time 60 min	Time 120 min
1	Normal Control	-	87.2 ± 0.837	87.2 ± 0.834	87.8 ± 0.735	87.8 ± 0.583
2	Normal Control + UFG	40 mg/kg	86.8 ± 0.735	86.4 ± 0.734	84.4 ± 0.245	80.8 ± 0.583
3	Glucose Control	-	88.8 ± 0.861	140.4 ± 2.315	135 ± 1.143	129 ± 1.963
4	UFG I	10 mg/kg	88.4 ± 0.734	139.4 ± 1.158^ns	127.8 ± 1.021^*	106 ± 1.145^***
5	UFG II	20 mg/kg	87.4 ± 1.077	130 ± 1.158^*	116.6 ± 1.435^**	101.4 ± 1.032^***
6	UFG III	40 mg/kg	88.8 ± 0.734	124.8 ± 1.497^**	109 ± 0.732^***	87 ± 1.789^***
7	Glibenclamide	10 mg/kg	89 ± 0.707	125 ± 1.068^**	111.4 ± 1.034^***	88.6 ± 1.568^***

All values represent mean ± SEM * P < 0.05; ** P < 0.01; *** P < 0.001, ns < non significant; ANOVA, followed by Dunnett’s multiple comparison test.

ISSN: 2662-7671